Introduction

Living with persistent knee osteoarthritis pain can be tough, often affecting your mobility and day-to-day activities. As more people look for effective, long-lasting pain relief beyond painkillers or surgery, Arthrosamid injections are becoming a popular treatment option. These minimally invasive injections use a special hydrogel to help reduce inflammation and improve joint movement. This article will explore how long relief from Arthrosamid typically lasts and the factors that can affect its success.

One of the most common questions patients ask is, “How long will Arthrosamid last?” Here, we bring together the latest scientific research, clinical insights from experts like Professor Paul Lee, and practical advice to help you understand what to expect from this treatment and how to manage your knee osteoarthritis in the long term.

Understanding Arthrosamid Injection: Duration and Effectiveness

Arthrosamid contains a 2.5% cross-linked polyacrylamide hydrogel mixed with purified water. When injected into the knee, it acts like a cushion and scaffold that sticks to the lining of the joint, helping to soothe inflammation and improve lubrication. The whole procedure is quick, performed under local anaesthetic, and avoids the need for surgery.

Research shows that Arthrosamid injections provide pain relief and improved joint function for at least two years. A recent review found “statistically significant data at both 52 weeks and 13 months,” with some studies showing benefits lasting up to two years. This makes Arthrosamid a longer-lasting option compared with other injections, like hyaluronic acid, which may require more frequent treatments. This extended relief is due to the hydrogel’s stable composition, which remains inside the joint without breaking down quickly.

However, it’s important to remember that while Arthrosamid offers lasting benefits, a recent study found that it “offers comparable short-term efficacy and modest advantage at 6 months. However, long-term superiority is limited.” So although it is effective, the difference compared with other treatments may lessen over time.

On the safety front, Arthrosamid has an excellent record. Studies confirm that “injection of PAAG hydrogel into the knee has been shown to be safe with no long-lasting adverse effects.” Common side effects, such as temporary swelling or stiffness, typically clear up quickly. Further lab research supports this reassuring safety profile, reporting that “2.5 iPAAG had no statistically significant effects on cell survival, apoptotic or non-apoptotic cell death, or neurite network area” in human nerve cells, confirming it poses no neurotoxic or harmful effects on a cellular level.

Factors That Affect Relief Longevity

How long you benefit from Arthrosamid injections can vary, depending on several key factors. The severity of osteoarthritis is crucial—people with mild to moderate joint damage often see longer-lasting improvements than those with more advanced wear and tear. Your activity level also matters; putting too much strain on the knee can shorten the relief period. Lastly, following advice on aftercare, such as physical therapy and lifestyle changes, helps maintain the injection’s effects.

Clinical guidance plays a big role here. Experts like Professor Paul Lee and the MSK Doctors team tailor treatment plans that optimise injection technique and provide personalised follow-up care. This attention to detail can make a real difference in how long the benefits last. For example, one study found that “iPAAG showed the highest patient acceptable symptom state rates (72%, 54%, and 42% at 3, 6, and 12 months),” illustrating how patients generally tolerate and respond well to this treatment over time.

Recognising When Arthrosamid Relief May Be Wearing Off

It’s important to recognise the signs if your Arthrosamid injection starts to lose its effectiveness. Typically, you might notice pain slowly returning, more swelling, or stiffness making everyday movements harder. If you find your knee becoming uncomfortable during normal activities or waking up feeling stiff, it might be time to seek advice.

Keeping a record of your symptoms and discussing them openly with your healthcare provider is crucial. Clinics like MSK Doctors offer a friendly, professional environment where specialists can review your progress and recommend next steps if needed, helping you stay on top of your condition.

Options When Relief Diminishes: What Next?

If your knee pain comes back after Arthrosamid, don’t worry—there are several options to consider. Some patients find that repeat Arthrosamid injections can provide another period of relief. Other treatments to explore include platelet-rich plasma (PRP) or microfragmented adipose tissue (mFAT) injections. And if necessary, further orthopaedic evaluation can determine if surgery might be the best choice.

Whatever stage you’re at, it’s essential to work with skilled clinicians. Specialists such as Professor Paul Lee and the MSK Doctors team are continually developing and offering personalised, non-surgical treatments designed to help you manage pain and keep active for as long as possible.

Conclusion

To sum up, Arthrosamid injections generally offer effective knee osteoarthritis relief for one to two years. Research confirms that “this PAAG hydrogel seems to be an efficacious and safe treatment option for knee osteoarthritis and provides positive results for at least 2 years.” How long you experience relief depends on factors like the severity of your condition, activity levels, and following professional aftercare guidance. While “long-term superiority is limited,” Arthrosamid remains a valuable part of a personalised osteoarthritis management plan.

For anyone considering this treatment, consulting experienced orthopaedic specialists ensures you get up-to-date, evidence-based care suited to your needs. With the right support, you can take control of your knee pain and improve your quality of life.

References

• Cole, A., Maulana, R., Whitehead, J., & Lee, P. (2022). A systematic review of the novel compound Arthrosamid polyacrylamide (PAAG) hydrogel for treatment of knee osteoarthritis. Medical Research Archives, 10(8). https://doi.org/10.18103/mra.v10i8.2950
• Aykaç, B., Dinç, M., Nar, Ö. O., Karasu, R., & Bayrak, H. Ç. (2025). Comparative efficacy of polyacrylamide hydrogel versus hyaluronic acid and corticosteroids in knee osteoarthritis: A retrospective cohort study. Medicine, 104(7), e44655. https://doi.org/10.1097/MD.0000000000044655
• Walmod, P. S., Kusk, P., Jøhnk, N., Ankorina‐Stark, I., & Essex, A. (2025). An injectable 2.5% cross-linked polyacrylamide hydrogel (2.5 iPAAG) demonstrates no neurotoxicity in human induced pluripotent stem cells-derived iCell® GlutaNeurons. Frontiers in Toxicology. https://doi.org/10.3389/ftox.2025.1585430